GS 5CC (Requip XL 8 mg)
Generic Name: ropinirole
Pill with imprint GS 5CC is Red, Elliptical/Oval and has been identified as Requip XL 8 mg. It is supplied by GlaxoSmithKline.
Requip XL is used in the treatment of periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip XL 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GS 5CC
Requip XL
- Generic Name
- ropinirole
- Imprint
- GS 5CC
- Strength
- 8 mg
- Color
- Red
- Size
- 13.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00007-4888 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
glyceryl dibehenate,
hydrogenated castor oil,
hypromelloses,
lactose monohydrate,
magnesium stearate,
maltodextrin,
mannitol,
povidone,
hypromellose 2910 (6 mPa.s),
titanium dioxide,
polyethylene glycol 400,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about Requip XL (ropinirole)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (7)
- Drug images
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.